skip to content
Primary navigation


DrugVecamyl™ [Manchester Pharmaceuticals]

October 2013

Therapeutic area - Cardiovascular

Approval criteria

  • Patient has a diagnosis of hypertension AND
  • Patient has previously been treated for hypertension with drugs from three of the following classes: diuretics, beta blockers, ACE inhibitors, ARBs

Quantity limit

  • 340 tablets per 34-day supply

Background information

Vecamyl™ is indicated for the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension.


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top